Cargando…
Fragment approaches in structure-based drug discovery
There has been considerable interest recently in what is known as ‘fragment-based lead discovery’. The novel feature of the approach is to begin with small low-affinity compounds. The main advantage is that a larger potential chemical diversity can be sampled with fewer compounds, which is particula...
Autor principal: | Hubbard, Roderick E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394783/ https://www.ncbi.nlm.nih.gov/pubmed/18421145 http://dx.doi.org/10.1107/S090904950705666X |
Ejemplares similares
-
Interaction of HIV-1 aspartic protease with its inhibitor, by molecular dynamics and ab initio fragment molecular orbital method
por: Koyano, Kazuo, et al.
Publicado: (2008) -
Diffraction structural biology – a new horizon
por: Yamane, Takashi, et al.
Publicado: (2013) -
Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034
por: Madison, Vincent, et al.
Publicado: (2008) -
Protein structures by spallation neutron crystallography
por: Langan, Paul, et al.
Publicado: (2008) -
Approach for growth of high-quality and large protein crystals
por: Matsumura, Hiroyoshi, et al.
Publicado: (2011)